<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2010</study_start_year><condition>Colorectal Cancer</condition><condition>Colorectal Neoplasms</condition><disease>Colorectal Cancer</disease><disease>Colorectal Neoplasms</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2094455</full_dataset_link><location>China</location><study_start_month>8</study_start_month><keyword>5-fluorouracil</keyword><keyword>Chemotherapy</keyword><keyword>Advanced colorectal cancer</keyword><keyword>S-1</keyword><keyword>Levoleucovorin</keyword><keyword>Leucovorin</keyword><keyword>Elderly patients</keyword><keyword>Fluorouracil</keyword><repository>ECRIN MDR</repository><study_status>Not provided</study_status></additional><is_claimable>false</is_claimable><name>S-1/Leucovorin (SL) Versus sLV5FU2 as the First-line Treatment for Elderly Patients With Colorectal Cancer</name><description>This phase II trial on the assumption that S-1 combined with Leucovorin may have better efficacy and safety than simplified 5-FU/LV infusion therapy in elderly patients with advanced colorectal cancer.</description><dates><creation>2010-08-15</creation></dates><accession>2094455</accession><cross_references><ClinicalTrials___gov>NCT01193452</ClinicalTrials___gov></cross_references></HashMap>